TXNIP and Hyperglycemia: Therefore, a calcium blockade by pharmaceutical intervention can effectively target not 1, but several β-cell fragilities associated with hyperglycemia-induced metabolic stress through the downregulation of proapoptotic factor TxNIP and reduce extracellular proapoptotic signaling via IGFBP3.